시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 신속 진단 키트 시장 보고서(2025년)
Rapid Diagnostic Test Kits Global Market Report 2025
상품코드 : 1769729
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,310,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,121,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,932,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

신속 진단 키트 시장 규모는 향후 수 년간 강력한 성장이 예상될 예정입니다. 이러한 미래 성장은 가정 내 진단 솔루션 사용 증가, 신흥 시장에 대한 의료 투자 증가, 빠른 질병 발견에 대한 선호도 증가, 국제 보건 기관의 지원 강화, 탈중앙화 의료 모델로의 전환으로 뒷받침될 것입니다.

포인트 오브 케어와 재택 검사에 대한 주목 증가가 향후 몇 년간의 신속 진단 키트 시장의 성장을 견인할 것으로 예측됩니다. 이러한 유형의 검사는 환자 치료 현장이나 가정 내에서 직접 수행되는 전통적인 실험실 환경 외에서 신속하고 편리한 결과를 제공하여 적시에 의료 결정을 내리는 데 도움이 되는 진단 절차를 의미합니다. 검사실 진찰의 필요성을 없애고, 대기 시간을 단축해, 자택에 있으면서 건강 관리를 서포트하는 보다 신속하고 간편한 건강 평가를 요구하는 개인이 늘어나고 있기 때문에 포인트 오브 케어 검사나 재택 검사 수요가 높아지고 있습니다. 전문적인 장비를 필요로 하지 않고 신속하고 신뢰할 수 있는 결과를 제공함으로써 이러한 요구를 보완하고 기존 검사실 이외의 시기 적절한 판단을 가능하게 합니다. 2022년 8월, 미국 질병통제예방센터(CDC)는 2021년부터 2022년까지 미국에서 1,070만 건의 자가 코로나19 검사 결과가 자발적으로 제출되었다고 보고했는데, 이는 기존 방식에서 자가 검사로의 전환을 강조하는 결과입니다. 그 결과, 포인트 오브 케어나 재택 검사에 대한 주목이 높아지고 있어, 신속 진단 검사 키트 시장의 확대에 크게 기여하고 있습니다.

시장 경쟁에서 기업은 경쟁 우위를 유지하기 위해 타액 기반 임신 검사 키트와 같은 혁신적인 솔루션에 대한 투자를 늘리고 있습니다. 이 키트는 여성의 타액에서 호르몬 변화, 특히 인간 융모막 성선자극호르몬(hCG)을 식별하여 임신을 감지하도록 설계되었습니다. 2023년 2월 영국에 본사를 둔 진단제 회사 Abingdon Health plc는 영국과 아일랜드에서 최초의 신속 타액 기반 임신 검사인 Salistick을 도입했습니다. 이 제품은 전통적인 소변 기반 방법에 비해 더 깨끗하고 사용자 친화적인 대안을 제공함으로써 가정 임신 테스트에서 주목할 만한 발전을 이루었습니다. 이 고정밀 검사약을 통해 여성은 타액을 사용하여 임신을 조기에 발견할 수 있어 언제 어디서나 검사가 가능하고, 보다 신중하고 공유하기 쉬운 체험을 제공합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Rapid diagnostic test kits are portable, user-friendly medical devices designed to swiftly identify the presence or absence of particular diseases, infections, or medical conditions. These kits often provide results within minutes, making them essential for point-of-care testing, early detection, and prompt treatment decisions in both clinical and remote environments.

The primary product categories of rapid diagnostic test kits include antigen test kits, antibody test kits, nucleic acid test kits, and multi-analyte test kits. Antigen test kits function by detecting specific proteins from pathogens, such as viruses, to promptly confirm active infections. These kits are segmented by technology into fluorescent immunoassay, enzyme-linked immunosorbent assay, colloidal gold-based test, and lateral flow assays. They are also classified by application areas, such as infectious disease testing, cardiology testing, oncology testing, pregnancy and fertility testing, toxicology testing, glucose monitoring, and others. The key end-users of these kits include hospitals, diagnostic laboratories, home care settings, and pharmacies.

The rapid diagnostic test kits market research report is one of a series of new reports from The Business Research Company that provides rapid diagnostic test kits market statistics, including the rapid diagnostic test kits industry global market size, regional shares, competitors with the rapid diagnostic test kits market share, detailed rapid diagnostic test kits market segments, market trends, and opportunities, and any further data you may need to thrive in the rapid diagnostic test kits industry. This rapid diagnostic test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rapid diagnostic test kits market size has grown strongly in recent years. It will grow from $22.66 billion in 2024 to $24.08 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The historical growth was driven by the increasing incidence of infectious diseases, growing popularity of point-of-care diagnostics, heightened demand for early detection during health crises, enhanced government investments in controlling infectious diseases, and broader adoption of rapid tests in underserved and rural regions.

The rapid diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $30.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. This future growth will be supported by increased use of at-home diagnostic solutions, rising healthcare investments in emerging markets, growing preference for rapid disease detection, enhanced backing from international health agencies, and a shift toward decentralized models of healthcare. Key trends expected in the market include innovations in microfluidic diagnostic systems, smartphone-compatible testing tools, the rise of multi-target rapid testing kits, advancements in personalized testing methods, and growing investment in diagnostic innovation and R&D.

The increasing focus on point-of-care and at-home testing is anticipated to drive the growth of the rapid diagnostic test kits market in the coming years. These types of testing refer to diagnostic procedures conducted outside traditional laboratory settings, either directly at the site of patient care or within the home, offering quick and convenient results that facilitate timely medical decisions. The demand for point-of-care and at-home testing is rising as individuals seek faster and more convenient health assessments that eliminate the need for laboratory visits, reduce wait times, and support health management from the comfort of their homes. Rapid diagnostic test kits complement these needs by providing quick, reliable results without requiring specialized equipment, thus enabling timely decisions outside conventional labs. For example, in August 2022, the Centers for Disease Control and Prevention reported that during 2021-2022, 10.7 million at-home COVID-19 test results were voluntarily submitted in the United States, underscoring the shift toward self-testing over traditional methods. As a result, the growing focus on point-of-care and at-home testing is contributing significantly to the expansion of the rapid diagnostic test kits market.

Companies in the rapid diagnostic test kits market are increasingly investing in innovative solutions such as saliva-based pregnancy test kits to maintain a competitive advantage. These kits are designed to detect pregnancy by identifying hormonal changes, particularly human chorionic gonadotropin (hCG), in a woman's saliva. For instance, in February 2023, Abingdon Health plc, a diagnostics company based in the UK, introduced Salistick, the first rapid saliva-based pregnancy test in the UK and Ireland. This product represents a notable advancement in home pregnancy testing by offering a cleaner and more user-friendly alternative to traditional urine-based methods. The highly accurate test allows women to detect pregnancy at an early stage using saliva, enabling testing to be conducted anytime and anywhere, and offering a more discreet and shareable experience.

In June 2023, Avacta Group, a biotechnology firm headquartered in the UK, completed the acquisition of Coris Bioconcept SRL for $8.42 million. This acquisition is intended to enhance Avacta's diagnostics portfolio by incorporating Coris's range of rapid test products and expertise. The move strengthens Avacta's capabilities in both centralized laboratory diagnostics and decentralized point-of-care testing, reinforcing its presence in the growing sectors of infectious disease and antimicrobial resistance diagnostics. Coris Bioconcept SRL, based in Belgium, develops and supplies rapid diagnostic kits for identifying respiratory, gastrointestinal, and blood-borne pathogens in humans.

Major players in the rapid diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., OraSure Technologies Inc., Nova Biomedical Corporation, Sekisui Diagnostics LLC, EKF Diagnostics Holdings plc, Trinity Biotech plc, ACON Laboratories Inc., Fluxergy LLC, Lumos Diagnostics Holdings Limited, Abingdon Health plc, and Abionic SA.

North America was the largest region in the rapid diagnostic test kits market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rapid diagnostic test kits report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rapid diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rapid diagnostic test kits market consists of sales of influenza test kits, malaria test kits, pregnancy test kits, glucose monitoring kits, hepatitis test kits, and dengue test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rapid Diagnostic Test Kits Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rapid diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for rapid diagnostic test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The rapid diagnostic test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Rapid Diagnostic Test Kits Market Characteristics

3. Rapid Diagnostic Test Kits Market Trends And Strategies

4. Rapid Diagnostic Test Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Rapid Diagnostic Test Kits Growth Analysis And Strategic Analysis Framework

6. Rapid Diagnostic Test Kits Market Segmentation

7. Rapid Diagnostic Test Kits Market Regional And Country Analysis

8. Asia-Pacific Rapid Diagnostic Test Kits Market

9. China Rapid Diagnostic Test Kits Market

10. India Rapid Diagnostic Test Kits Market

11. Japan Rapid Diagnostic Test Kits Market

12. Australia Rapid Diagnostic Test Kits Market

13. Indonesia Rapid Diagnostic Test Kits Market

14. South Korea Rapid Diagnostic Test Kits Market

15. Western Europe Rapid Diagnostic Test Kits Market

16. UK Rapid Diagnostic Test Kits Market

17. Germany Rapid Diagnostic Test Kits Market

18. France Rapid Diagnostic Test Kits Market

19. Italy Rapid Diagnostic Test Kits Market

20. Spain Rapid Diagnostic Test Kits Market

21. Eastern Europe Rapid Diagnostic Test Kits Market

22. Russia Rapid Diagnostic Test Kits Market

23. North America Rapid Diagnostic Test Kits Market

24. USA Rapid Diagnostic Test Kits Market

25. Canada Rapid Diagnostic Test Kits Market

26. South America Rapid Diagnostic Test Kits Market

27. Brazil Rapid Diagnostic Test Kits Market

28. Middle East Rapid Diagnostic Test Kits Market

29. Africa Rapid Diagnostic Test Kits Market

30. Rapid Diagnostic Test Kits Market Competitive Landscape And Company Profiles

31. Rapid Diagnostic Test Kits Market Other Major And Innovative Companies

32. Global Rapid Diagnostic Test Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rapid Diagnostic Test Kits Market

34. Recent Developments In The Rapid Diagnostic Test Kits Market

35. Rapid Diagnostic Test Kits Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기